Liu Zhenyu, Li Junjuan, Wang Kun, Tan Qiang, Tan Wei, Guo Guifang
1 School of Basic Medical Sciences, Harbin Medical University , Harbin, Heilongjiang, China .
2 Department of Respiratory Medicine, Weifang People's Hospital , Weifang, Shandong, China .
Genet Test Mol Biomarkers. 2018 Jul;22(7):433-442. doi: 10.1089/gtmb.2017.0238. Epub 2018 Jun 29.
Asthma is the most common chronic pulmonary disease in China and is characterized by airway inflammation and episodic airflow obstruction. The aim of this meta-analysis was to evaluate the relation of two transforming growth factor-β1 (TGF-β1) polymorphisms with asthma risk in Chinese population.
PubMed, Springer, EMBASE, MEDLINE, CNKI (China National Knowledge Infrastructure), and Wanfang databases were used to search and retrieve relevant eligible case-control studies published through December 2017. The odds ratios (OR) and 95% confidence intervals (CI) were used to evaluate the effect.
A total of 2040 asthma patients and 1952 controls from 12 studies were analyzed. Two polymorphic sites of TGF-β1 gene were identified: -509C/T and +869T/C. We found that the -509C/T polymorphism was associated with increased asthma risk under the heterozygous model (CT vs. CC: OR = 1.40, 95% CI = 1.03-1.90, p = 0.03) and the dominant model (TT+CT vs. CC: OR = 1.41, 95% CI = 1.05-1.90, p = 0.02). Subgroup analyses by age suggested that -509C/T variant was associated with childhood asthma. Analysis of disease severity indicated that this variant was associated with both mild-to-moderate asthma and severe asthma. However, the +869T/C polymorphism was not associated with asthma susceptibility in subgroup analysis by age or disease severity.
This study demonstrated that the -509C/T polymorphism of the TGF-β1 gene might be a risk factor for asthma in the Chinese population, especially in Chinese children. Further large-scale case-control studies are still required.
哮喘是中国最常见的慢性肺部疾病,其特征为气道炎症和发作性气流阻塞。本荟萃分析的目的是评估中国人群中两种转化生长因子-β1(TGF-β1)基因多态性与哮喘风险的关系。
使用PubMed、Springer、EMBASE、MEDLINE、中国知网(CNKI)和万方数据库检索并获取截至2017年12月发表的相关合格病例对照研究。采用比值比(OR)和95%置信区间(CI)评估效应。
对12项研究中的2040例哮喘患者和1952例对照进行了分析。确定了TGF-β1基因的两个多态性位点:-509C/T和+869T/C。我们发现,在杂合子模型(CT vs. CC:OR = 1.40,95%CI = 1.03 - 1.90,p = 0.03)和显性模型(TT + CT vs. CC:OR = 1.41,95%CI = 1.05 - 1.90,p = 0.02)下,-509C/T多态性与哮喘风险增加相关。按年龄进行的亚组分析表明,-509C/T变异与儿童哮喘相关。疾病严重程度分析表明,该变异与轻度至中度哮喘和重度哮喘均相关。然而,在按年龄或疾病严重程度进行的亚组分析中,+869T/C多态性与哮喘易感性无关。
本研究表明,TGF-β1基因的-509C/T多态性可能是中国人群尤其是中国儿童哮喘的危险因素。仍需进一步开展大规模病例对照研究。